Greenlight Capital »

Gain Therapeutics shares owned by Greenlight Capital

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Greenlight Capital from 13F filings

Historical chart of Greenlight Capital investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Greenlight Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Greenlight Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.9M 588k 3.27
2023-09-30 $1.9M 588k 3.28
2023-06-30 $2.4M 547k 4.48
2023-03-31 $2.6M 547k 4.82
2022-12-31 $1.7M 547k 3.13
2022-09-30 $1.8M 547k 3.26
2022-06-30 $2.0M 547k 3.59
2022-03-31 $2.2M 547k 4.09
2021-12-31 $3.0M 547k 5.43
2021-09-30 $4.1M 547k 7.45
2021-06-30 $5.5M 547k 10.00
2021-03-31 $8.2M 547k 14.92